Case studies showing clinical signs and management of cutaneous toxicity of the MEK1/2 inhibitor AZD6244 (ARRY-142886) in patients with solid tumours.

Thumbnail
Fulltext:
88064timmer-bonte.pdf
Embargo:
until further notice
Size:
1.014Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2010
Author(s)
Desar, I.M.E.
Bovenschen, H.J.
Timmer-Bonte, J.N.H.
Cantarini, M.V.
Graaf, W.T.A. van der
Rossum, M.M. van
Herpen, C.M.L. van
Source
Acta Oncologica, 49, 1, (2010), pp. 110-3
ISSN
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/88064   https://hdl.handle.net/2066/88064
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.